The results demonstrated that SphK1 was a direct target of miR-124 in HNSCC, inhibiting the SphK1 expression by specifically binding with the complementary 3′-UTR sequence motif of SphK1. This evidence concerns the gene SPHK1 and head and neck squamous cell carcinoma.